Employee Spotlight with Carlo Wouters
Carlo joined Lensai (IPA) as Head of Technology in 2022, bringing with him over two decades of...
BioStrand Omics Analysis Blog
Our omics analysis blog brings insights into genetics and genomics research solutions, and their leading role in the development of this industry.
Key elements of successful AI-native drug discovery
The use of AI in drug discovery has been progressively expanding over the past decade. Over the...
What is a biomarker?
A biomarker, or biological marker, broadly refers to a range of objectively, accurately, and...
Precision drugs for the precision medicine era
Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...
Employee Spotlight with Tom Vieijra
In our Employee Spotlight series, we focus on key individuals from our growing network of thought...
What is precision medicine?
In 1999, an innovative collaboration between 10 of the world’s largest pharmaceutical companies,...
The role of NGS in breast cancer diagnosis and treatment
Breast cancer is the most common cancer in women worldwide, accounting for 25% of all female...
Explained: how to plot the prediction quality metrics with AlphaFold2
In a previous blog post, we discussed the importance of AlphaFold2 (as well as other, deep-learning...
IPA MedTech Entrepreneurship Story at TU Delft
My name is Christophe Van Neste, Ph. D. and I am a bioinformatician and data scientist at IPA,...
A brief retrospective on our second blogiversary
It’s been an eventful two years, to the month, since we launched our omics and analysis blog. Our...
AI in Biopharma: Challenges and Opportunities
There are an estimated novemdecillion, or 1060, molecules in the known universe with potential...